These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 34147124)

  • 1. Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect.
    Zhou X; Yu L; Zhou M; Hou P; Yi L; Mi M
    Nutr Metab (Lond); 2021 Jun; 18(1):64. PubMed ID: 34147124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway.
    Zhao Y; Liu X; Ding C; Gu Y; Liu W
    Front Pharmacol; 2021; 12():783886. PubMed ID: 34867416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
    Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI
    PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.
    Jeong WI; Park O; Gao B
    Gastroenterology; 2008 Jan; 134(1):248-58. PubMed ID: 18166357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice.
    Jeong WI; Park O; Suh YG; Byun JS; Park SY; Choi E; Kim JK; Ko H; Wang H; Miller AM; Gao B
    Hepatology; 2011 Apr; 53(4):1342-51. PubMed ID: 21480338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice.
    Yi HS; Lee YS; Byun JS; Seo W; Jeong JM; Park O; Duester G; Haseba T; Kim SC; Park KG; Gao B; Jeong WI
    Hepatology; 2014 Sep; 60(3):1044-53. PubMed ID: 24668648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl Acetate Fraction of Dicliptera chinensis (L.) Juss. Ameliorates Liver Fibrosis by Inducing Autophagy via PI3K/AKT/mTOR/p70S6K Signaling Pathway.
    Liu Y; Bi YM; Pan T; Zeng T; Mo C; Sun B; Gao L; Lyu ZP
    Chin J Integr Med; 2022 Jan; 28(1):60-68. PubMed ID: 34105096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
    Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
    Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
    Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
    J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
    Chen W; Zhang Z; Yao Z; Wang L; Zhang F; Shao J; Chen A; Zheng S
    Int Immunopharmacol; 2018 Mar; 56():148-155. PubMed ID: 29414645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvia Miltiorrhiza Ameliorates Liver Fibrosis by Activating Hepatic Natural Killer Cells
    Peng Y; Yang T; Huang K; Shen L; Tao Y; Liu C
    Front Pharmacol; 2018; 9():762. PubMed ID: 30061833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.
    Shi J; Zhao J; Zhang X; Cheng Y; Hu J; Li Y; Zhao X; Shang Q; Sun Y; Tu B; Shi L; Gao B; Wang FS; Zhang Z
    Sci Rep; 2017 Mar; 7():44544. PubMed ID: 28291251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethylfumarate ameliorates hepatic injury and fibrosis induced by carbon tetrachloride.
    Mostafa ME; Shaaban AA; Salem HA
    Chem Biol Interact; 2019 Apr; 302():53-60. PubMed ID: 30703375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway.
    Guo M; Wang Z; Dai J; Fan H; Yuan N; Gao L; Peng H; Cheng X
    Phytomedicine; 2023 Apr; 112():154587. PubMed ID: 36805480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic acid phenethyl ester attenuates liver fibrosis via inhibition of TGF-β1/Smad3 pathway and induction of autophagy pathway.
    Yang N; Dang S; Shi J; Wu F; Li M; Zhang X; Li Y; Jia X; Zhai S
    Biochem Biophys Res Commun; 2017 Apr; 486(1):22-28. PubMed ID: 28193525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway.
    Zhang YZ; Yao JN; Zhang LF; Wang CF; Zhang XX; Gao B
    World J Gastroenterol; 2019 Jun; 25(24):3044-3055. PubMed ID: 31293340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the molecular mechanism of dihydromyricetin in alleviating liver cirrhosis based on network pharmacology.
    Wei L; Li X; Yao Y; Wang S; Ai X; Liu S
    Chem Biol Drug Des; 2024 Jan; 103(1):e14421. PubMed ID: 38230771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.